1097 |
Integrating IVUS, FFR, and Non-Invasive Imaging to Optimize PCI Outcomes |
Gary S. Mintz |
May. 03. 10 |
1096 |
Cointerpoint: When is PCI an Acceptable or Preferred Alternative? |
Paul S. Teirstein |
May. 03. 10 |
1095 |
Point: When is Surgery the Preferred Therapy? |
David Paul Taggart |
May. 03. 10 |
1094 |
Therapy in Evolution: Percutaneous Aortic Valve Replacement |
Martin Bert Leon |
May. 03. 10 |
1093 |
Alternative and Next Antiplatelet Therapy Beyond ADP Blocker |
Duk-Woo Park |
May. 03. 10 |
1092 |
Ticagrelor: PLATO - A New Chapters Opens |
Matthew Price |
May. 03. 10 |
1091 |
Prasugrel: TRITON - Evolution Begins Here !! |
David E. Kandzari |
May. 03. 10 |
1090 |
Clopidogrel: Current OASIS7 - Double Is Better !! |
David Joel Cohen |
May. 03. 10 |
1089 |
Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation |
Seung-Jung Park |
Mar. 16. 10 |
1088 |
Double-Dose vs Standard-Dose Clopidogrel in ACS Patients Undergoing PCI for STEMI |
|
Mar. 15. 10 |